Sign In
Buy GDRX
$2.57
-0.0900 (-3.38%)
At Close: Jun 22, 2026
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
09:00am, Wednesday, 15'th Apr 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that the new higher dose Wegovy® HD (semaglutide) injection 7.
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access
Reviewing GoodRx (NASDAQ:GDRX) & Nutex Health (NASDAQ:NUTX)
01:10am, Wednesday, 25'th Mar 2026
Nutex Health (NASDAQ: NUTX - Get Free Report) and GoodRx (NASDAQ: GDRX - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses
GoodRx (NASDAQ:GDRX) versus Biocorrx (OTCMKTS:BICX) Critical Comparison
01:46am, Monday, 23'rd Mar 2026
Biocorrx (OTCMKTS:BICX - Get Free Report) and GoodRx (NASDAQ: GDRX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
09:00am, Wednesday, 11'th Mar 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced a new collaboration with Viatris, a global healthcare company,
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®
09:00am, Friday, 06'th Mar 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound® (tirzepatide) KwikPen®
First Look: Broadcom (AVGO) AI Beat; Tech Power Pledge
07:38am, Thursday, 05'th Mar 2026
Stock News Futures wobble as oil surges: U.S. stock futures edged lower while oil extended gains amid the Iran conflict, even as megacap tech like Nvidia (NVDA)
GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript
03:17pm, Thursday, 26'th Feb 2026
GoodRx Holdings, Inc. (GDRX) Q4 2025 Earnings Call Transcript
GoodRx Targets Digital Subscription Growth Amid 14% Dip in Active Consumers
11:40am, Thursday, 26'th Feb 2026
The prescription experience has started to resemble other parts of digital commerce: shoppers want clear pricing, fewer handoffs and a quicker path from decision to fulfillment. That push toward self-
Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings
10:31am, Thursday, 26'th Feb 2026
While the top- and bottom-line numbers for GoodRx (GDRX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
GoodRx Reports Fourth Quarter and Full Year 2025 Results
04:05pm, Wednesday, 25'th Feb 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has releas
GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”
09:00am, Tuesday, 24'th Feb 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced the launch of GoodRx Employer Direct. The new offering enables
GoodRx (NASDAQ:GDRX) vs. Teladoc Health (NYSE:TDOC) Financial Comparison
01:39am, Thursday, 19'th Feb 2026
GoodRx (NASDAQ: GDRX - Get Free Report) and Teladoc Health (NYSE: TDOC - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesse
Novo Nordisk has launched its Wegovy GLP-1 drug in pill form. Amazon is getting into the fight, offering ease and low costs to customers who buy the Wegovy pill on its platform.
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
07:44pm, Thursday, 05'th Feb 2026
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is a key integration partner for pharmaceutical compani
